As regards retinal dystrophies, most advanced therapeutic approaches that target splicing are aimed at correcting the splicing of individual genes using mutation-adapted U1 small nuclear RNA for the RPGR gene45 or spliceosome-mediated RNA trans-splicing in RHO46. The gene discussed is RPGR; the disease is Retinal dystrophy.